JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$5.47B |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.17B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$2.05B |
| 4 |
Amazon
AMZN
|
+$1.96B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$1.72B |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$1.31B |
| 3 |
UnitedHealth
UNH
|
+$1.26B |
| 4 |
Automatic Data Processing
ADP
|
+$1.17B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.08B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.28% |
| 2 | Technology | 17.17% |
| 3 | Healthcare | 10.79% |
| 4 | Financials | 9.36% |
| 5 | Consumer Discretionary | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1601
Andersons Inc
ANDE
$2.27B
| $20.3M | ﹤0.01% |
491,421
+73,524
| +18% | +$2.9M |
2013 Q2
39 quarters
|
|
1602
Gentex
GNTX
$4.62B
| $20.3M | ﹤0.01% |
724,351
+120,622
| +20% | +$3.4M |
2013 Q2
39 quarters
|
|
1603
Bio-Rad Laboratories Class A
BIO
$10.2B
| $20.3M | ﹤0.01% |
42,350
+9,179
| +28% | +$4.3M |
2013 Q2
39 quarters
|
|
1604
Vanguard Morningstar Mid-Cap Value ETF
VOE
$23.4B
| $20.3M | ﹤0.01% |
151,101
-3,965
| -3% | -$550K |
2016 Q1
28 quarters
|
|
1605
Popular Inc
BPOP
$10.1B
| $20.2M | ﹤0.01% |
351,392
-99,255
| -22% | -$6.46M |
2013 Q2
39 quarters
|
|
1606
CALL
Mastercard
MA
$495B
| $20.2M | ﹤0.01% |
55,500
-53,000
| -49% | -$19.3M |
2020 Q4
9 quarters
|
|
1607
Louisiana-Pacific
LPX
$4.57B
| $20.2M | ﹤0.01% |
371,748
-61,554
| -14% | -$3.77M |
2015 Q4
29 quarters
|
|
1608
Dine Brands
DIN
$378M
| $20.1M | ﹤0.01% |
297,604
-1,162
| -0.4% | -$85.2K |
2013 Q2
39 quarters
|
|
1609
Unitil
UTL
$924M
| $20.1M | ﹤0.01% |
352,902
+100,420
| +40% | +$5.36M |
2013 Q2
39 quarters
|
|
1610
Alerian MLP ETF
AMLP
$12.9B
| $20.1M | ﹤0.01% |
520,221
-259,999
| -33% | -$10.2M |
2013 Q2
39 quarters
|
|
1611
Sony
SONY
$138B
| $20M | ﹤0.01% |
1,105,730
+147,045
| +15% | +$2.55M |
2013 Q2
39 quarters
|
|
1612
iShares MSCI ACWI ETF
ACWI
$33.3B
| $20M | ﹤0.01% |
219,536
-47,257
| -18% | -$4.22M |
2013 Q2
39 quarters
|
|
1613
CALL
Applied Materials
AMAT
$430B
| $20M | ﹤0.01% |
162,600
-117,400
| -42% | -$13.5M |
2020 Q4
9 quarters
|
|
1614
PUT
Peloton Interactive
PTON
$2.2B
| $19.9M | ﹤0.01% |
1,758,900
+2,600
| +0.1% | +$31.3K |
2021 Q1
8 quarters
|
|
1615
Bank OZK
OZK
$5.08B
| $19.9M | ﹤0.01% |
583,228
+99,134
| +20% | +$4.16M |
2013 Q2
39 quarters
|
|
1616
Avista
AVA
$2.94B
| $19.9M | ﹤0.01% |
468,205
-116,844
| -20% | -$4.84M |
2013 Q2
39 quarters
|
|
1617
Sensient Technologies
SXT
$5.5B
| $19.9M | ﹤0.01% |
259,449
+151,210
| +140% | +$11.3M |
2013 Q2
39 quarters
|
|
|
LSXMA
1618
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
| $19.8M | ﹤0.01% |
959,682
-1,709,815
| -64% | -$42.9M |
2016 Q2
27 quarters
|
|
1619
USA Compression Partners
USAC
$3.68B
| $19.8M | ﹤0.01% |
936,955
-99,436
| -10% | -$2.05M |
2022 Q4
1 quarter
|
|
1620
Endava
DAVA
$101M
| $19.7M | ﹤0.01% |
293,835
+249,499
| +563% | +$19.6M |
2020 Q1
12 quarters
|
|
1621
CALL
Amgen
AMGN
$218B
| $19.7M | ﹤0.01% |
81,400
+70,800
| +668% | +$17.4M |
2014 Q3
34 quarters
|
|
1622
Liberty Latin America Class C
LILAK
$1.72B
| $19.6M | ﹤0.01% |
2,615,158
+232,901
| +10% | +$1.85M |
2015 Q3
30 quarters
|
|
1623
AerCap
AER
$22.5B
| $19.6M | ﹤0.01% |
349,165
+87,233
| +33% | +$5.22M |
2015 Q3
30 quarters
|
|
1624
Royal Gold
RGLD
$19.8B
| $19.6M | ﹤0.01% |
151,269
+23,820
| +19% | +$2.93M |
2013 Q2
39 quarters
|
|
|
HI
1625
DELISTED
Hillenbrand
HI
| $19.6M | ﹤0.01% |
412,645
+21,152
| +5% | +$971K |
2015 Q4
29 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2023 Portfolio in Review
As of Q1 2023, JP Morgan Chase held 7,579 positions worth $821B, up 8.2% from $759B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q1 2023 filing shows 751 new, 3,314 increased, 2,056 reduced and 652 closed positions. Its largest new stake was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M. The largest sale was Eli Lilly, an estimated $1.72B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 27% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q1 2023 buy was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q1 2023, an estimated $5.47B increase.
- JP Morgan Chase's biggest Q1 2023 reduction was Eli Lilly, cutting an estimated $1.72B.
- JP Morgan Chase fully exited IAA, Inc. Common Stock in Q1 2023, selling an estimated $155M.
- JP Morgan Chase's ten largest holdings make up 17% of its $821B portfolio in Q1 2023.
- JP Morgan Chase opened 751 new positions and closed 652 in Q1 2023.
- JP Morgan Chase's portfolio value rose 8.2% quarter-over-quarter to $821B.
Based on JP Morgan Chase's 13F filing for Q1 2023, filed 11 May 2023.